Atara Biotherapeutics (ATRA) Asset Utilization Ratio (2021 - 2026)
Atara Biotherapeutics (ATRA) posted Asset Utilization Ratio of 1.15 for Q1 2026, down 76.0% on a QoQ basis from 4.79 in Q4 2025, and down 50.72% year-over-year from 2.33 in Q1 2025.
Atara Biotherapeutics (ATRA) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Atara Biotherapeutics' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 1.15 for Q1 2026.
- Quarterly Asset Utilization Ratio fell 50.72% year-over-year to 1.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.15 (down 50.72% YoY) and the FY2025 annual result came in at 1.87, up 98.87% from the prior year.
- Asset Utilization Ratio was 1.15 for Q1 2026 at Atara Biotherapeutics, down from 4.79 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 4.79 in Q4 2025 and bottomed at 0.0 in Q4 2023.
- A 5-year average of 1.16 and a median of 0.17 in 2023 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio plunged 99.79% — and 2024, when it surged 312693.99%.
- Atara Biotherapeutics' Asset Utilization Ratio stood at 0.16 in 2022, then slumped by 99.79% to 0.0 in 2023, then surged by 312693.99% to 1.02 in 2024, then jumped by 367.94% to 4.79 in 2025, then sank by 76.0% to 1.15 in 2026.
- Business Quant data shows ATRA's Asset Utilization Ratio at 1.15 in Q1 2026, 4.79 in Q4 2025, and 4.53 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | 1.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 |
| Dec 31, 2025 | 4.79 |
| Sep 30, 2025 | 4.53 |
| Jun 30, 2025 | 3.81 |
| Mar 31, 2025 | 2.33 |
| Dec 31, 2024 | 1.02 |
| Sep 30, 2024 | 0.72 |
| Jun 30, 2024 | 0.39 |
| Mar 31, 2024 | 0.16 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.17 |
| Dec 31, 2022 | 0.16 |
| Sep 30, 2022 | 0.16 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.04 |
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.03 |
| Jun 30, 2021 | 0.02 |